Pixelgen Technologies

Pixelgen Technologies AB develops the Proximity Network Assay, a DNA-based method for spatial analysis of cell surface proteins on single cells. Its products include the Pixelgen Proxiome Kit v2, the Immuno 155 panel, CAR T profiling products, a custom conjugation kit and the Pixelator software for processing assay data.

The company sells research kits and software to life science researchers and translational research groups, with pharmaceutical customers also named on its website. The website shows requests for quotes and a list of academic collaborators including Karolinska Institutet, SciLifeLab and KTH. The company describes itself as venture-backed, with investors named as Navigare Ventures, Colibri Ventures and Fibonacci Growth Capital.

Pixelgen was founded in Stockholm, Sweden in 2020. Its website lists a Series B round of $15.5M and open roles for a Software Engineer and a Research Associate at its headquarters.

Product: Proximity Network Assay research kits (Proxiome Kit v2, Immuno 155, CAR T panels, custom conjugation kit) and the Pixelator analysis software.